FIELD: biochemistry.
SUBSTANCE: present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, enantiomer or stereoisomer thereof, which can be used to treat gastrointestinal polyps, intestinal polyps and inflammatory bowel disease, as well as a pharmaceutical composition containing it,
Formula I,
wherein R1, R3, R5 are missing;
each of R2, R4 independently represents
R6 is
.
EFFECT: present invention can be used to treat gastrointestinal polyps, intestinal polyps and inflammatory bowel disease.
5 cl, 9 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR TREATING CANCER | 2017 |
|
RU2770081C2 |
COMPOSITIONS AND METHODS FOR TREATMENT OF XEROSTOMIA | 2017 |
|
RU2749189C2 |
2-PHENYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2005 |
|
RU2375347C2 |
CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
FLUOROPHENYL-BETA-HYDROXYETHYLAMINES AND THEIR USE FOR THE TREATMENT OF HYPERGLYCEMIA | 2018 |
|
RU2801096C2 |
SOLUBLE C5aR ANTAGONISTS | 2017 |
|
RU2748260C2 |
SUBSTITUTED IMIDAZOQUINOLINES | 2018 |
|
RU2768629C2 |
CONDENSED AROMATIC DIFLUOROMETHANE PHOSPHONATES AS PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) INHIBITORS | 2008 |
|
RU2462469C2 |
NEW TETRACYCLIC CYSTEIN PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF AND APPLICATION THEREOF | 2007 |
|
RU2481349C2 |
NOVEL COMPOUNDS, USE AND PRODUCTION THEREOF | 2009 |
|
RU2493152C2 |
Authors
Dates
2021-06-07—Published
2017-04-19—Filed